
Jeplus.in
Purchase All Medicines.Get 10% Offer

Pharma Tech
Repligenâs $1.5bn purchase of BioLife Solutions adds CryoStor biopreservation to its bioprocessing portfolio, underscoring pharmaâs shift toward integrated cell and gene therapy supply chains.

Pharma Tech
Recommended changes to the US immunisation schedule by President Trump have been met with widespread retaliation.

Pharma Tech
Summit Therapeuticsâ partner Akeso has secured Chinaâs NMPA authorisation for the use of ivonescimab in combination with chemotherapy as a first-line treatment for advanced squamous NSCLC patients.

Pharma Tech
Eli Lilly is suing several US companies that are allegedly selling illegal versions of its weight loss candidate, retatrutide.

Pharma Tech
Remepy has secured $36m in Series A funds to accelerate its pharmaceutical co-development partnerships and expand its hybrid drug pipeline.
Sponsored content

Purchase All Medicines.Get 10% Offer
News
PharmaShots
Aug 13, 2026, 1:30 PM
Shots:Â The post PharmaShots Magazine-Aug-2026 Edition appeared first on PharmaShots.
PharmaShots
Aug 13, 2026, 12:30 PM
Shots: Ref: Pharming Group  |  Image: Pharming Group |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us atconnect@pharmashots.com The post Pharming Group Launches Joenja in Japan for APDS appeared first on PharmaShots.
PharmaShots
Aug 13, 2026, 11:30 AM
Shots: Ref: Businesswire |  Image: Definium Therapeutics |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Definium Therapeutics Reports P-III (Voyage) Study on DT120 ODT in Generalized Anxiety Disorder (GAD) appeared first on PharmaShots.
ET Pharma
Aug 13, 2026, 10:53 AM
Novo was first to bring a highly effective âGLP-1 weight-loss injection, Wegovy, â to the â U.S. market, but is under pressure to regain ground lost to Lilly's Zepbound in a business that analysts expect will be worth more than $100 billion âa year by 2030.
PharmaShots
Aug 13, 2026, 10:30 AM
Shots: Ref: Globenewswire |  Image: Freenome |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us atconnect@pharmashots.com The post Freenomeâs SimpleScreen Lung Cancer Screening Test Secures Breakthrough Device Designation appeared first on PharmaShots.
Pharma Tech
Aug 13, 2026, 10:20 AM
Repligenâs $1.5bn purchase of BioLife Solutions adds CryoStor biopreservation to its bioprocessing portfolio, underscoring pharmaâs shift toward integrated cell and gene therapy supply chains.
News
Google News
Aug 13, 2026, 4:09 PM
CPHI Milan Puts Sustainability to Work, Part 1Â Â PharmTech.com
Google News
Aug 13, 2026, 3:57 PM
Kirklandâs EIT Pharma Announces Milestone for Drug Treating Chronic Hepatitis DÂ Â 425business.com
Google News
Aug 13, 2026, 3:41 PM
Lee Kang-young Receives Handok Academic Management Award  쥰ě ěźëł´
Google News
Aug 13, 2026, 3:33 PM
Humana agrees not to reference Teva's Israel ties at US drug trial  Reuters
Google News
Aug 13, 2026, 3:33 PM
Humana agrees not to reference Teva's Israel ties at US drug trial  reuters.com
Google News
Aug 13, 2026, 3:33 PM
Obesity not a 'zero-sum game' as patients crave optionality, Novo CEO says: Reuters  Fierce Pharma
Google News
Aug 13, 2026, 3:33 PM
Update: Market Chatter: Novartis Wins UK Court Challenge to Entresto Patent  Yahoo Finance
Google News
Aug 13, 2026, 3:26 PM
Indiaâs Q1 pharma exports up 6.8% to $8.1bn; U.S. remains largest export destination  The Hindu
Google News
Aug 13, 2026, 3:06 PM
Medicare Update: Proposed Change Could Lower Drug Costs, AARP Report Shows  Newsweek
Sponsored placement

Purchase All Medicines.Get 10% Offer